ROS-Responsive Nanoprobes for Bimodal Imaging-Guided Cancer Targeted Combinatorial Therapy
MIBFP NPs constitute a novel dual-modality imaging-guided drug delivery system for targeted breast cancer therapy and offer precise and controlled combined treatment options.
Authors
- Jiuquan Zhang (ORCID: https://orcid.org/0000-0003-0239-6988)
- Ying Cao (ORCID: https://orcid.org/0000-0001-9073-4558)
- Xiaoxia Wang (ORCID: https://orcid.org/0000-0003-1888-9154)
- Lu Wang (ORCID: https://orcid.org/0000-0001-5861-6404)
- Huifang Chen (ORCID: https://orcid.org/0000-0003-2016-1082)
- Yao Huang (ORCID: https://orcid.org/0000-0002-6690-8658)
- Meng Meng Lin (ORCID: https://orcid.org/0000-0003-0196-9780)
- Fujie Jiang (ORCID: https://orcid.org/0000-0002-6273-3571)
- Shuling Liu
Institutions
- Chongqing University (CN)
- Chongqing Cancer Hospital (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/ijn.s467512
- Citations
- 7
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Chongqing University
- Natural Science Foundation of Chongqing
- Centre Scientifique et Technique du Bâtiment
- Research and Innovation Foundation
- Fundamental Research Funds for the Central Universities